AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY

The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheim...

Full description

Saved in:
Bibliographic Details
Main Authors Vesterager, Louise Buur, Montezinho, Liliana Christina Pereira, Bergstrôm, Ann-Louise, Rademaker, Rik, Vink, Tom, Satijn, David, Malik, Ibrahim John, Kallunki, Pekka, Sotty, Florence, Van Den Brink, Edward, Parren, Paul, Fog, Karina
Format Patent
LanguageEnglish
Published 05.12.2019
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Online AccessGet full text

Cover

More Information
Summary:The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy.
Bibliography:Application Number: US201916443249